VCXB WS / 10X Capital Venture Acquisition Corp. III - Equity Warrant - Документы SEC, Годовой отчет, Доверенное заявление

10X Capital Venture Acquisition Corp. III — Варрант на акции
US ˙ NYSEAM

Основная статистика
CIK 1848948
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to 10X Capital Venture Acquisition Corp. III - Equity Warrant
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
July 26, 2024 EX-99.25

EX-99.25

EX-99.25 2 ruleprovisionnotice.htm NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES NYSE American LLC hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on August 06, 2024, pursuant to the provisions of Rule 12d2-2 (a). [ X ] 17 CFR 240.12d2-2(a)(1) T

July 11, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2024 10X CAPITAL VENTURE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inco

July 10, 2024 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 10, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inco

July 8, 2024 EX-99.25

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES NYSE American LLC ("NYSE American" or the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.

June 28, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

June 28, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2024 10X CAPITAL VENTURE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inco

June 21, 2024 EX-10.1

MUTUAL TERMINATION OF MERGER AGREEMENT

Exhibit 10.1 MUTUAL TERMINATION OF MERGER AGREEMENT This Mutual Termination of Merger Agreement (this “Agreement”), dated as of June 21, 2024, is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“Acquiror”), 10X AGT Merger Sub, LLC, a Delaware limited liability company and wholly-owned subsidiary of Acquiror (“Merger Sub”), and American Gene T

June 21, 2024 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inco

June 10, 2024 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

May 15, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

May 10, 2024 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of incorp

May 10, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 10X CAPITAL VENTURE A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of incorp

April 23, 2024 EX-99.1

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing New York, NY, April 23, 2024 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated April 17, 2024 (the “Notice”), notified 10X III that it was not in compliance with the N

April 23, 2024 EX-99.1

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing New York, NY, April 23, 2024 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated April 17, 2024 (the “Notice”), notified 10X III that it was not in compliance with the N

April 23, 2024 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inc

April 23, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2024 10X CAPITAL VENTUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inc

April 1, 2024 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

March 11, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 10X CAPITAL VENTUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inc

March 11, 2024 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inc

February 14, 2024 SC 13G/A

VCXB / 10X Capital Venture Acquisition Corp. III / Radcliffe Capital Management, L.P. - SC 13G/A Passive Investment

SC 13G/A 1 tm245838d36sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1) 10X Capital Venture Acquisition Corp. III (Name of Issuer) Class A ordinary shares, par value $0.0

February 14, 2024 SC 13G/A

VCXB / 10X Capital Venture Acquisition Corp. III / Sandia Investment Management LP Passive Investment

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* 10X Capital Venture Acquisition Corp. III (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G87077106 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] R

February 9, 2024 SC 13G/A

VCXB / 10X Capital Venture Acquisition Corp. III / Saba Capital Management, L.P. - FORM SC 13G/A Passive Investment

SC 13G/A 1 formsc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* 10X Capital Venture Acquisition Corp. III (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) G87077106 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this St

January 31, 2024 8-K

Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

January 31, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2024 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

January 31, 2024 EX-99.1

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance New York, NY, Jan. 31, 2024 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB, VCXB.U, VCXB WS) (“10X III”), announced today that NYSE Regulation (“NYSER”), by letter dated January 29, 2024 (the “Notice”), notified 10X III that it is not currently in compliance with S

January 31, 2024 EX-99.1

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance New York, NY, Jan. 31, 2024 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB, VCXB.U, VCXB WS) (“10X III”), announced today that NYSE Regulation (“NYSER”), by letter dated January 29, 2024 (the “Notice”), notified 10X III that it is not currently in compliance with S

January 10, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 10X CAPITAL VENTU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

January 10, 2024 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

January 9, 2024 EX-99.1

10X Capital Venture Acquisition Corp. III Announces Expected Change in Management

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Announces Expected Change in Management NEW YORK, NY (United States), Jan. 08, 2024 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (“10X III”) (NYSE American:VCXB), a publicly traded special purpose acquisition company, announced today that, subject to approval by the board of directors, it expects David Weisburd, the current Chi

January 9, 2024 EX-10.1

JOINDER to LETTER Agreement

Exhibit 10.1 Execution Version JOINDER to LETTER Agreement This Joinder to Letter Agreement (this “Joinder”) is made this 9th day of January, 2024, by Osman Ahmed (the “Officer”), in respect of that certain Letter Agreement (the “Letter Agreement”), dated as of January 11, 2022, by and among 10X Capital SPAC Sponsor III LLC (the “Sponsor”), 10X Capital Venture Acquisition Corp. III (the “Company”)

January 9, 2024 EX-99.1

10X Capital Venture Acquisition Corp. III Announces Expected Change in Management

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Announces Expected Change in Management NEW YORK, NY (United States), Jan. 08, 2024 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (“10X III”) (NYSE American:VCXB), a publicly traded special purpose acquisition company, announced today that, subject to approval by the board of directors, it expects David Weisburd, the current Chi

January 9, 2024 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 10X CAPITAL VENTU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

January 9, 2024 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

January 9, 2024 EX-10.1

JOINDER to LETTER Agreement

Exhibit 10.1 Execution Version JOINDER to LETTER Agreement This Joinder to Letter Agreement (this “Joinder”) is made this 9th day of January, 2024, by Osman Ahmed (the “Officer”), in respect of that certain Letter Agreement (the “Letter Agreement”), dated as of January 11, 2022, by and among 10X Capital SPAC Sponsor III LLC (the “Sponsor”), 10X Capital Venture Acquisition Corp. III (the “Company”)

December 5, 2023 425

2

Filed by 10X Capital Venture Acquisition Corp. III pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: 10X Capital Venture Acquisition Corp. III (Commission File No. 001-41216) Date: December 5, 2023 The following is a transcript of an interview with Jeff Galvin, Chief Exec

November 28, 2023 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of

November 28, 2023 EX-99.1

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing New York, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated November 21, 2023 (the “Notice”), notified 10X III that it was not in compliance with the

November 28, 2023 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2023 10X CAPITAL VEN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of

November 28, 2023 EX-99.1

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing New York, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated November 21, 2023 (the “Notice”), notified 10X III that it was not in compliance with the

November 27, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41216 10X CAPIT

November 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

November 13, 2023 EX-21.1

List of Subsidiaries of 10X Capital Venture Acquisition Corp. III

Exhibit 21.1 List of Subsidiaries of 10X Capital Venture Acquisition Corp. III Name of Subsidiary Jurisdiction of Organization 10X AGT Merger Sub, LLC Delaware

November 13, 2023 EX-FILING FEES

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables FORM S-4 (Form Type) 10X CAPITAL VENTURE ACQUISITION CORP.

November 13, 2023 EX-4.6

Form of 2019 Promissory Note, issued by American Gene Technologies International Inc. for the benefit of certain noteholders.

Exhibit 4.6 PROMISSORY NOTE $xxx,xxx , 20xx For value received, American Gene Technologies International Inc., a Delaware corporation (the “Company”), hereby unconditionally promises to pay to the order of [Investor] or its assigns (“Holder”), in lawful money of the United States of America and in immediately available funds, the principal sum amount set forth above, or such lesser amount as shall

November 13, 2023 EX-4.8

Form of 2023 Senior Secured Convertible Promissory Note, issued by American Gene Technologies International Inc. for the benefit of certain noteholders.

Exhibit 4.8 THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES EVIDENCED BY THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT COVERING SUCH SECURITIES OR AN APPLICABLE EXEMPTION FROM REGISTRATION UNDER THE ACT. SENIO

November 13, 2023 EX-10.19

Form of Senior Secured Convertible Promissory Note Purchase Agreement, dated October 31, 2023, by and between American Gene Technologies International Inc. and the individuals and entities party thereto.

Exhibit 10.19 AMERICAN GENE TECHNOLOGY INTERNATIONAL INC. Senior Secured Convertible Promissory NOTE PURCHASE AGREEMENT THIS Secured Convertible Promissory NOTE PURCHASE AGREEMENT (as amended and/or restated from time to time, this “Agreement”), is made as of October 31, 2023 by and between American Gene Technologies International Inc., a Delaware corporation (the “Company”), and each of the indiv

November 13, 2023 EX-10.18

Form of Note and Warrant Purchase Agreement, effective February 25, 2022, by and between American Gene Technologies International Inc. and the Purchasers party thereto.

Exhibit 10.18 AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. FORM OF NOTE AND WARRANT PURCHASE AGREEMENT This Note and Warrant Purchase Agreement (the “Agreement”) is made as of February 25, 2022 (the “Effective Date”) by and among American Gene Technologies International Inc., a Delaware corporation (the “Company”), and the persons and entities named on the Schedule of Purchasers attached hereto (

November 13, 2023 S-4

As filed on November 13, 2023

As filed on November 13, 2023 No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III* (Exact name of registrant as specified in its charter) Cayman Islands* 6770 98-1611637 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification C

November 13, 2023 EX-4.7

Form of 2022 Promissory Note, issued by American Gene Technologies International Inc. for the benefit of certain noteholders

Exhibit 4.7 PROMISSORY NOTE $xxx,xxx , 20xx For value received, American Gene Technologies International Inc., a Delaware corporation (the “Company”), hereby unconditionally promises to pay to the order of [Investor] or its assigns (“Holder”), in lawful money of the United States of America and in immediately available funds, the principal sum amount set forth above, or such lesser amount as shall

November 13, 2023 EX-10.21

Form of Intellectual Property Security Agreement, dated as of October 31, 2023, by and among American Gene Technologies International Inc. in favor of Wilmington Trust, National Association, as collateral agent on behalf of the Investors listed on the signature pages thereof.

Exhibit 10.21 Execution Version INTELLECTUAL PROPERTY SECURITY AGREEMENT This Intellectual Property Security Agreement (“Agreement”) is executed on October 31, 2023 by American Gene Technologies International Inc., a Delaware corporation (together with its successors and assigns, “Grantor”), in favor of Wilmington Trust, National Association, a national banking association, as collateral agent (in

November 13, 2023 EX-3.5

Certificate of Incorporation of American Gene Technologies International Inc.

Exhibit 3.5 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. American Gene Technologies International Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), certifies that: 1. The name of the Corporation is American Gene Technologies International Inc. The Corporation’s original Certificate of Incorp

November 13, 2023 EX-10.20

Form of Security Agreement, dated as of October 31, 2023, by and among American Gene Technologies International Inc. in favor of Wilmington Trust, National Association, as collateral agent on behalf of the Investors listed on the signature pages thereof.

Exhibit 10.20 EXECUTION VERSION SECURITY AGREEMENT This Security Agreement (as amended, modified or otherwise supplemented from time to time, this “Security Agreement”), dated as of October 31, 2023, is executed by American Gene Technologies International Inc., a Delaware corporation (together with its successors and assigns, the “Company”), in favor of Wilmington Trust, National Association, as c

November 13, 2023 EX-10.17

Form of Note and Warrant Purchase Agreement, effective February 14, 2019, by and between American Gene Technologies International Inc. and the purchasers party thereto.

Exhibit 10.17 AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. FORM OF NOTE AND WARRANT PURCHASE AGREEMENT This Note And Warrant Purchase Agreement (the “Agreement”) is made as of February 14, 2019 (the “Effective Date”) by and among American Gene Technologies International Inc., a Delaware corporation (the “Company”), and the persons and entities named on the Schedule of Purchasers attached hereto (

November 13, 2023 EX-3.6

Bylaws of American Gene Technologies International Inc.

Exhibit 3.6 BYLAWS OF AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. Adopted September 5, 2008 TABLE OF CONTENTS Page Article I MEETINGS OF STOCKHOLDERS 1 1.1 Place of Meetings 1 1.2 Annual Meeting 1 1.3 Special Meeting 1 1.4 Notice of Stockholders’ Meetings 1 1.5 Quorum 2 1.6 Adjourned Meeting; Notice 2 1.7 Conduct of Business 2 1.8 Voting 2 1.9 Stockholder Action by Mitten Consent Without a Meeti

November 8, 2023 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

November 8, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

October 26, 2023 425

2

Filed by 10X Capital Venture Acquisition Corp. III pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: 10X Capital Venture Acquisition Corp. III (Commission File No. 001-41216) Date: October 24, 2023 Transcript of Speech by Jeff Galvin, CEO of American Gene Technologies Int

October 16, 2023 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0080 Washington, D.

October 13, 2023 EX-3.1

Amendment to Second Amended and Restated Memorandum and Articles of Association of 10X III.

Exhibit 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman 10X Capital Venture Acquisition Corp. III (ROC # 371478) (the “Company”) TAKE NOTICE that at an Extraordinary General Meeting of the shareholders of the Company held on the 12th October 2023, the following special resolutions were passed: 1. RESOLVED, as a special resolution, that the Se

October 13, 2023 EX-3.1

Amendment to Second Amended and Restated Memorandum and Articles of Association (Incorporated by reference to the Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on October 13, 2023)

Exhibit 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman 10X Capital Venture Acquisition Corp. III (ROC # 371478) (the “Company”) TAKE NOTICE that at an Extraordinary General Meeting of the shareholders of the Company held on the 12th October 2023, the following special resolutions were passed: 1. RESOLVED, as a special resolution, that the Se

October 13, 2023 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2023 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

October 13, 2023 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

October 12, 2023 425

Filed by 10X Capital Venture Acquisition Corp. III pursuant to

Filed by 10X Capital Venture Acquisition Corp. III pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: 10X Capital Venture Acquisition Corp. III (Commission File No. 001-41216) Date: October 11, 2023 American Gene Technologies® to Present at ROTH MKM 2023 Healthcare Opportu

October 6, 2023 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 10X Capital Venture Acquisition Corp. III (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 98-1611637 (State or other jurisdiction of incorporation or organization) (I.R.S. Emp

October 6, 2023 EX-10.1

Form of Non-Redemption Agreement (incorporated by reference to Exhibit 10.1 to 10X III’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on October 6, 2023).

Exhibit 10.1 FORM OF NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST This Non-Redemption Agreement and Assignment of Economic Interest (this “Agreement”) is entered as of October 5, 2023 by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the “Sponsor”) and the

October 6, 2023 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2023 10X CAPITAL VENTU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

October 6, 2023 EX-10.1

Form of Non-Redemption Agreement.

Exhibit 10.1 FORM OF NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST This Non-Redemption Agreement and Assignment of Economic Interest (this “Agreement”) is entered as of October 5, 2023 by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the “Sponsor”) and the

October 6, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

October 6, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

October 5, 2023 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2023 10X CAPITAL VENTU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

October 5, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2023 10X CAPITAL VENTU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of in

October 5, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

October 5, 2023 EX-99.1

10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U, VCXB, VCXB WS) (“10X III”) today announced that it is transferring the listing of its Class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), redeemable w

October 5, 2023 EX-99.1

10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American

Exhibit 99.1 10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) - 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U, VCXB, VCXB WS) (“10X III”) today announced that it is transferring the listing of its Class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), redeemable w

September 28, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

September 12, 2023 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission

August 21, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41216 10X CAPITAL VE

August 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

August 10, 2023 425

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

Filed by 10X Capital Venture Acquisition Corp. III pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: 10X Capital Venture Acquisition Corp. III (Commission File No. 001-41216) Date: August 10, 2023 Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, t

August 10, 2023 EX-2.1

Agreement and Plan of Merger, dated as of August 9, 2023, by and among 10X Capital Venture Acquisition Corp. III, 10X AGT Merger Sub, LLC and American Gene Technologies International Inc

Exhibit 2.1 AGREEMENT AND PLAN OF MERGER dated as of August 9, 2023 by and among 10X CAPITAL VENTURE ACQUISITION Corp. III, 10X AGT Merger Sub, LLC, and AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 4 1.01 Definitions 4 1.02 Construction 22 ARTICLE II THE MERGER; CLOSING 23 2.01 The Merger 23 2.02 Effects of the Merger 23 2.03 Closing 23 2.04 Or

August 10, 2023 EX-10.2

Form of Company Support Agreement

Exhibit 10.2 FORM OF COMPANY SUPPORT AGREEMENT This COMPANY SUPPORT AGREEMENT (this “Agreement”) is entered into as of [ ● ], 2023, by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“10X”), [ ● ], a [ ● ] (the “Stockholder”), and, solely with respect to Sections 1 - 3 hereof, American Gene Technologies International Inc., a Delaware corporation (the “Compan

August 10, 2023 EX-10.3

Form of Lock-Up Agreement

Exhibit 10.3 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of [ ● ], 2023 between [ ● ], a [ ● ] (the “Stockholder”)1, and Addimmune Inc. (f/k/a 10X Capital Venture Acquisition Corp. III), a Delaware corporation (“Addimmune”). The Stockholder and Addimmune are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

August 10, 2023 EX-10.3

Form of Lock-Up Agreement

Exhibit 10.3 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of [ ● ], 2023 between [ ● ], a [ ● ] (the “Stockholder”)1, and Addimmune Inc. (f/k/a 10X Capital Venture Acquisition Corp. III), a Delaware corporation (“Addimmune”). The Stockholder and Addimmune are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

August 10, 2023 EX-10.1

Acquiror Support Agreement, dated August 9, 2023, by and among 10X Capital Venture Acquisition Corp. III, American Gene Technologies International Inc., 10X Capital SPAC Sponsor III LLC and the directors and executive officers of 10X Capital Venture Acquisition Corp. III named therein

Exhibit 10.1 ACQUIROR SUPPORT AGREEMENT This ACQUIROR SUPPORT AGREEMENT (this “Agreement”), dated as of August 9, 2023, is made by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“10X” or “Acquiror”), American Gene Technologies International Inc., a Delaware corporation (“AGT”), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (th

August 10, 2023 425

Filed by 10X Capital Venture Acquisition Corp. III

Filed by 10X Capital Venture Acquisition Corp. III pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: 10X Capital Venture Acquisition Corp. III (Commission File No. 001-41216) Date: August 10, 2023 On August 10, 2023, 10X Capital published the following post on LinkedIn: B

August 10, 2023 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 10X CAPITAL VENTUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inc

August 10, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 10X CAPITAL VENTUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inc

August 10, 2023 EX-10.1

Acquiror Support Agreement, dated August 9, 2023, by and among 10X Capital Venture Acquisition Corp. III, American Gene Technologies International Inc., 10X Capital SPAC Sponsor III LLC and the directors and executive officers of 10X Capital Venture Acquisition Corp. III named therein

Exhibit 10.1 ACQUIROR SUPPORT AGREEMENT This ACQUIROR SUPPORT AGREEMENT (this “Agreement”), dated as of August 9, 2023, is made by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“10X” or “Acquiror”), American Gene Technologies International Inc., a Delaware corporation (“AGT”), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (th

August 10, 2023 EX-99.1

# # #

Exhibit 99.1 ADDIMMUNETM, A CLINICAL STAGE HIV-FOCUSED GENE THERAPY COMPANY, TO GO PUBLIC THROUGH BUSINESS COMBINATION WITH 10X CAPITAL VENTURE ACQUISITION CORP. III ● Addimmune’s investigational cell therapy, AGT103-T, makes gene modifications to the patients’ immune cells (T cells) that harden those cells against HIV infection and depletion, thus allowing those cells to target and kill HIV inste

August 10, 2023 EX-99.1

# # #

Exhibit 99.1 ADDIMMUNETM, A CLINICAL STAGE HIV-FOCUSED GENE THERAPY COMPANY, TO GO PUBLIC THROUGH BUSINESS COMBINATION WITH 10X CAPITAL VENTURE ACQUISITION CORP. III ● Addimmune’s investigational cell therapy, AGT103-T, makes gene modifications to the patients’ immune cells (T cells) that harden those cells against HIV infection and depletion, thus allowing those cells to target and kill HIV inste

August 10, 2023 EX-10.2

Form of Company Support Agreement

Exhibit 10.2 FORM OF COMPANY SUPPORT AGREEMENT This COMPANY SUPPORT AGREEMENT (this “Agreement”) is entered into as of [ ● ], 2023, by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“10X”), [ ● ], a [ ● ] (the “Stockholder”), and, solely with respect to Sections 1 - 3 hereof, American Gene Technologies International Inc., a Delaware corporation (the “Compan

August 10, 2023 EX-2.1

Agreement and Plan of Merger, dated as of August 9, 2023, by and among 10X Capital Venture Acquisition Corp. III, 10X AGT Merger Sub, LLC and American Gene Technologies International Inc

Exhibit 2.1 AGREEMENT AND PLAN OF MERGER dated as of August 9, 2023 by and among 10X CAPITAL VENTURE ACQUISITION Corp. III, 10X AGT Merger Sub, LLC, and AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 4 1.01 Definitions 4 1.02 Construction 22 ARTICLE II THE MERGER; CLOSING 23 2.01 The Merger 23 2.02 Effects of the Merger 23 2.03 Closing 23 2.04 Or

July 11, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2023 10X CAPITAL VENTURE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of inco

May 23, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41216 10X CAPITAL V

May 23, 2023 EX-10.1

Second Amended and Restated Promissory Note, dated May 17, 2023, issued by the Company to the Sponsor.

Exhibit 10.1 THIS SECOND AMENDED AND RESTATED PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE A

May 22, 2023 8-K

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of incor

May 22, 2023 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-4

May 15, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

April 19, 2023 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 d480779dex991.htm EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of Class A ordinary shares, par value $0.0001 per share, of 10X Capital Venture Acquisition Corp. III (this

April 19, 2023 SC 13G

VCXB / 10X Capital Venture Acquisition Corp III - Class A / SPRING CREEK CAPITAL LLC - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 10X Capital Venture Acquisition Corp. III (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G87077106 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo

April 13, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41216 10X Capital Ven

April 13, 2023 EX-4.5

Description of Registrant’s Securities.

Exhibit 4.5 DESCRIPTION OF SECURITIES As of December 31, 2022, 10X Capital Venture Acquisition Corp. III (“we,” “our,” “us” or the “Company”) had the following three classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (“Units”), (ii)

April 13, 2023 EX-10.11

Amended and Restated Promissory Note, dated as of November 14, 2022, issued by the Company to the Sponsor.

Exhibit 10.11 THIS AMENDED AND RESTATED PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUB

March 31, 2023 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

February 14, 2023 SC 13G/A

VCXB / 10X Capital Venture Acquisition Corp III - Class A / Saba Capital Management, L.P. - FORM SC 13G/A Passive Investment

SC 13G/A 1 formsc13ga.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* 10X Capital Venture Acquisition Corp. III (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) G87077106 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this St

February 14, 2023 SC 13G/A

VCXB / 10X Capital Venture Acquisition Corp III - Class A / MMCAP International Inc. SPC - FORM SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

February 3, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

February 3, 2023 EX-10.1

Settlement Agreement and Mutual Release, dated as of February 2, 2023, by and among the Company, 10X Sparks Merger Sub, Inc., Sparks Energy, Inc. and Ottis Jarrada Sparks (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on February 3, 2023).

Exhibit 10.1 SETTLEMENT AGREEMENT AND MUTUAL RELEASE This Settlement Agreement and Release (“Settlement Agreement”) is entered into this 2nd day of February 2023 (the “Effective Date”), between 10X Capital Venture Acquisition Corp. III and 10X Sparks Merger Sub, Inc. (collectively, “Plaintiffs”), on the one hand, and Sparks Energy, Inc. (“Defendant”) and Ottis Jarrada Sparks, on the other. Plainti

February 1, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2023 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

February 1, 2023 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2023 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2023 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

February 1, 2023 EX-99.1

in the court of chancery of the state of delaware

Exhibit 99.1 in the court of chancery of the state of delaware 10X CAPITAL VENTURE ) ACQUISITION CORP. III, a Cayman ) Islands company, and 10X SPARKS ) MERGER SUB, INC., a Delaware ) corporation, ) C.A. No. - ) Plaintiffs, ) ) v. ) ) SPARKS ENERGY, INC., a Delaware ) corporation, ) ) Defendant. ) VERIFIED COMPLAINT Plaintiffs, 10X Capital Venture Acquisition Corp. III and 10X Sparks Merger Sub, I

February 1, 2023 EX-99.1

in the court of chancery of the state of delaware

Exhibit 99.1 in the court of chancery of the state of delaware 10X CAPITAL VENTURE ) ACQUISITION CORP. III, a Cayman ) Islands company, and 10X SPARKS ) MERGER SUB, INC., a Delaware ) corporation, ) C.A. No. - ) Plaintiffs, ) ) v. ) ) SPARKS ENERGY, INC., a Delaware ) corporation, ) ) Defendant. ) VERIFIED COMPLAINT Plaintiffs, 10X Capital Venture Acquisition Corp. III and 10X Sparks Merger Sub, I

January 13, 2023 SC 13G

KYG870771063 / 10X Capital Venture Acquisition Corp. III / Sandia Investment Management LP Passive Investment

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* 10X Capital Venture Acquisition Corp. III (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G87077106 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Ru

January 13, 2023 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS Exhibit 99.1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of January 13, 2023 is by and among Sandia Investment Management L.P. and Timothy J. Sichler (the foregoing are collectively referred to herein as the “Filers”). Each of the Filers may be required to file with the United States Securities and

December 29, 2022 SC 13G

KYG870771063 / 10X Capital Venture Acquisition Corp. III / Radcliffe Capital Management, L.P. - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. ) 10X Capital Venture Acquisition Corp. III (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities

December 28, 2022 EX-3.1

Second Amended and Restated Memorandum and Articles of Association of 10X III.

Exhibit 3.1 THE COMPANIES ACT (As Revised) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X Capital Venture Acquisition Corp. III (adopted by Special Resolution dated 28 December 2022) THE COMPANIES ACT (As Revised) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF 10X Ca

December 28, 2022 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of

December 28, 2022 EX-3.1

Second Amended and Restated Memorandum and Articles of Association (Incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on December 28, 2022).

Exhibit 3.1 THE COMPANIES ACT (As Revised) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X Capital Venture Acquisition Corp. III (adopted by Special Resolution dated 28 December 2022) THE COMPANIES ACT (As Revised) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF 10X Ca

December 28, 2022 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2022 10X CAPITAL VEN

425 1 ea170914-8k42510xcap3.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41

December 21, 2022 425

# # #

425 1 ea170627-42510xcapital3.htm FORM 425 Filed by 10X Capital Venture Acquisition Corp. III pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: 10X Capital Venture Acquisition Corp. III (Commission File No. 001-41216) Date: December 21, 2022 FOR IMMEDIATE RELEASE SPARKS E

December 21, 2022 EX-10.5

Standby Equity Purchase Agreement, dated December 20, 2022, by and between 10X Capital Venture Acquisition Corp. III and YA II PN, Ltd.

EX-10.5 6 ea170678ex10-510xcapital3.htm STANDBY EQUITY PURCHASE AGREEMENT, DATED DECEMBER 20, 2022, BY AND BETWEEN 10X CAPITAL VENTURE ACQUISITION CORP. III AND YA II PN, LTD Exhibit 10.5 STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of December 20, 2022 is made by and between YA II PN, LTD., a Cayman Islands exempt limited partnership (the “I

December 21, 2022 EX-99.1

# # #

EX-99.1 7 ea170678ex99-110xcapital3.htm PRESS RELEASE, DATED DECEMBER 21, 2022 Exhibit 99.1 FOR IMMEDIATE RELEASE SPARKS ENERGY, A LEADER IN POWER INFRASTRUCTURE SERVICES AND RESTORATION, TO LIST ON NEW YORK STOCK EXCHANGE THROUGH MERGER WITH 10X CAPITAL VENTURE ACQUISITION CORP. III ● Sparks Energy, Inc. (“Sparks”), a power infrastructure services firm and a leader in power restoration management

December 21, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 10X CAPITAL VEN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of

December 21, 2022 EX-10.3

Company Support Agreement, dated December 20, 2022, by and among 10X Capital Venture Acquisition Corp. III, Ottis J. Sparks and, solely with respect to Section 1(a) thereto, Sparks Energy, Inc.

Exhibit 10.3 COMPANY SUPPORT AGREEMENT This COMPANY SUPPORT AGREEMENT (this ?Agreement?) is entered into as of December 20, 2022, by and among 10x Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (?10X?), Ottis J. Sparks, a natural person (the ?Stockholder?), and, solely with respect to Section 1(a) hereto, Sparks Energy, Inc., a Delaware corporation (?Sparks Energy?). Each

December 21, 2022 EX-10.4

Form of Lock-Up Agreement.

Exhibit 10.4 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this ?Agreement?) is made and entered into as of [ ? ], 2023 between [ ? ], a [ ? ] (the ?Stockholder?)1 and 10x Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (?10X?). The Stockholder and 10X are sometimes referred to herein individually as a ?Party? and collectively as the ?Parties?. Capitalized terms used b

December 21, 2022 EX-10.4

Form of Lock-Up Agreement.

EX-10.4 5 ea170678ex10-410xcapital3.htm FORM OF LOCK-UP AGREEMENT Exhibit 10.4 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of [ ● ], 2023 between [ ● ], a [ ● ] (the “Stockholder”)1 and 10x Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“10X”). The Stockholder and 10X are sometimes referred to herein individually as a “

December 21, 2022 EX-10.3

Company Support Agreement, dated December 20, 2022, by and among 10X Capital Venture Acquisition Corp. III, Ottis J. Sparks and, solely with respect to Section 1(a) thereto, Sparks Energy, Inc.

Exhibit 10.3 COMPANY SUPPORT AGREEMENT This COMPANY SUPPORT AGREEMENT (this ?Agreement?) is entered into as of December 20, 2022, by and among 10x Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (?10X?), Ottis J. Sparks, a natural person (the ?Stockholder?), and, solely with respect to Section 1(a) hereto, Sparks Energy, Inc., a Delaware corporation (?Sparks Energy?). Each

December 21, 2022 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of

December 21, 2022 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of

December 21, 2022 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 10X CAPITAL VEN

425 1 ea170678-8k42510xcap3.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41

December 21, 2022 EX-10.2

Acquiror Support Agreement, dated December 20, 2022, by and among 10X Capital Venture Acquisition Corp. III, Sparks Energy, Inc., 10X Capital SPAC Sponsor III LLC and the directors and executive officers of 10X Capital Venture Acquisition Corp. III named therein

Exhibit 10.2 ACQUIROR SUPPORT AGREEMENT This ACQUIROR SUPPORT AGREEMENT (this ?Agreement?), dated as of December 20, 2022, is made by and among 10x Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (?10X?), Sparks Energy, Inc., a Delaware corporation (?Sparks Energy?), and 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the ?Sponsor?), and the u

December 21, 2022 EX-2.1

Agreement and Plan of Merger, dated as of December 20, 2022, by and among 10X Capital Venture Acquisition Corp. III, 10X Sparks Merger Sub, Inc. and Sparks Energy, Inc.

Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER dated as of December 20, 2022 by and among 10X CAPITAL VENTURE ACQUISITION Corp. III, 10X Sparks Merger Sub, Inc., and SPARKS ENERGY, INC. TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 3 1.01 Definitions 3 1.02 Construction 20 ARTICLE II THE MERGER; CLOSING 20 2.01 The Merger 20 2.02 Effects of the Merger 20 2.03 Closing 20 2.04 Org

December 21, 2022 EX-10.5

Standby Equity Purchase Agreement, dated December 20, 2022, by and between 10X Capital Venture Acquisition Corp. III and YA II PN, Ltd.

EX-10.5 6 ea170678ex10-510xcapital3.htm STANDBY EQUITY PURCHASE AGREEMENT, DATED DECEMBER 20, 2022, BY AND BETWEEN 10X CAPITAL VENTURE ACQUISITION CORP. III AND YA II PN, LTD Exhibit 10.5 STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of December 20, 2022 is made by and between YA II PN, LTD., a Cayman Islands exempt limited partnership (the “I

December 21, 2022 EX-10.2

Acquiror Support Agreement, dated December 20, 2022, by and among 10X Capital Venture Acquisition Corp. III, Sparks Energy, Inc., 10X Capital SPAC Sponsor III LLC and the directors and executive officers of 10X Capital Venture Acquisition Corp. III named therein.

Exhibit 10.2 ACQUIROR SUPPORT AGREEMENT This ACQUIROR SUPPORT AGREEMENT (this ?Agreement?), dated as of December 20, 2022, is made by and among 10x Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (?10X?), Sparks Energy, Inc., a Delaware corporation (?Sparks Energy?), and 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the ?Sponsor?), and the u

December 21, 2022 EX-99.1

# # #

Exhibit 99.1 FOR IMMEDIATE RELEASE SPARKS ENERGY, A LEADER IN POWER INFRASTRUCTURE SERVICES AND RESTORATION, TO LIST ON NEW YORK STOCK EXCHANGE THROUGH MERGER WITH 10X CAPITAL VENTURE ACQUISITION CORP. III ? Sparks Energy, Inc. (?Sparks?), a power infrastructure services firm and a leader in power restoration management, has entered into a merger agreement with 10X Capital Venture Acquisition Corp

December 21, 2022 EX-2.1

Agreement and Plan of Merger, dated as of December 20, 2022, by and among 10X Capital Venture Acquisition Corp. III, 10X Sparks Merger Sub, Inc. and Sparks Energy, Inc.

Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER dated as of December 20, 2022 by and among 10X CAPITAL VENTURE ACQUISITION Corp. III, 10X Sparks Merger Sub, Inc., and SPARKS ENERGY, INC. TABLE OF CONTENTS Page ARTICLE I CERTAIN DEFINITIONS 3 1.01 Definitions 3 1.02 Construction 20 ARTICLE II THE MERGER; CLOSING 20 2.01 The Merger 20 2.02 Effects of the Merger 20 2.03 Closing 20 2.04 Org

December 9, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2022 10X CAPITAL VENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of (

December 9, 2022 EX-10.1

Joinder to the Letter Agreement, dated December 8, 2022, between the Company, the Sponsor and Kash Sheikh (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on December 9, 2022).

Exhibit 10.1 Execution Version JOINDER to LETTER Agreement This Joinder to Letter Agreement (this ?Joinder?) is made this 8th day of December, 2022, by Kash Sheikh (the ?Director?), in respect of that certain Letter Agreement (the ?Letter Agreement?), dated as of January 11, 2022, by and among 10X Capital SPAC Sponsor III LLC (the ?Sponsor?), 10X Capital Venture Acquisition Corp. III (the ?Company

December 9, 2022 PRER14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use

December 9, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEF 14A 1 def14a122210xcapitalvent3.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary P

December 9, 2022 EX-10.1

Form of Non-Redemption Agreement (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on December 9, 2022).

Exhibit 10.1 NON-REDEMPTION AGREEMENT SPAC 10X Capital Venture Acquisition Corp. III, a Cayman Island exempted company (“SPAC”). Sponsor 10X Capital SPAC Sponsor III LLC Investor [ ] Investor Agreements Investor commits to own, prior to the date of the special meeting with respect to the SPAC’s shareholder vote in connection with the amendment of SPAC’s Amended and Restated Memorandum and Articles

December 9, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

November 17, 2022 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

PRE 14A 1 d411443dpre14a.htm PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Pr

November 14, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPO

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-

August 15, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PU

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41216

May 20, 2022 SC 13G

VCXB / 10X Capital Venture Acquisition Corp III - Class A / Saba Capital Management, L.P. - FORM SC 13G Passive Investment

SC 13G 1 formsc13g.htm FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* 10X Capital Venture Acquisition Corp. III (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) G87077106 (CUSIP Number) May 12, 2022 (Date of Event which Requires Filing of this Statement) Chec

May 16, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT P

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-4121

March 31, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

10-K 1 d279265d10k.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FI

March 31, 2022 EX-4.5

Description of Securities.

EX-4.5 2 d279265dex45.htm EX-4.5 Exhibit 4.5 DESCRIPTION OF SECURITIES 10X Capital Venture Acquisition Corp. III is a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Act and the common law of the Cayman Islands. Pursuant to our amended and restated memorandum and articles of association which was adopted

March 1, 2022 8-K

Financial Statements and Exhibits, Other Events

8-K 1 d312464d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 1, 2022 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1594494 (State or o

March 1, 2022 EX-99.1

10X Capital Venture Acquisition Corp. III Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing March 4, 2022

EX-99.1 2 d312464dex991.htm EX-99.1 Exhibit 99.1 10X Capital Venture Acquisition Corp. III Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing March 4, 2022 NEW YORK, March 1, 2022 (GLOBE NEWSWIRE) — 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U) (the “Company”) today announced that, commencing March 4, 2022, holders of the units sold in the Company’s initial p

February 15, 2022 SC 13D

10X Capital SPAC Sponsor III LLC - SC 13D

SC 13D 1 d226183dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* 10X Capital Venture Acquisition Corp. III (Name of Issuer) Class A Ordinary Shares, $0.0001 par value (Title of Class of Securities) G87077 106 (CUSIP Number) 1 World Trade Center, 85th Floor New York, NY 10007 (212) 257-

February 15, 2022 EX-99.1

JOINT FILING AGREEMENT

EX-99.1 2 d226183dex991.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT AGREEMENT dated as of February 14, 2022 by and between 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company, 10X Capital Advisors, LLC, a Delaware limited liability company, Hans Thomas and David Weisburd (together, the “Parties”). Each Party hereto represents to the other Party that it is eligible to u

January 21, 2022 SC 13G

MMCAP International Inc. SPC - FORM SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 10X Capital Venture Acquisition Corp.

January 21, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 14, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1611637 (State or other jurisdiction of i

January 21, 2022 EX-99.1

10X CAPITAL VENTURE ACQUISITION CORP. III Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of January 14, 2022 F-3 Notes to Financial Statement F-4

Exhibit 99.1 10X CAPITAL VENTURE ACQUISITION CORP. III Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of January 14, 2022 F-3 Notes to Financial Statement F-4 Report of Independent Registered Public Accounting Firm To the Shareholders and the Board of Directors of 10X Capital Venture Acquisition Corp. III Opinion on the Financial Statement We have audited the accompan

January 14, 2022 424B4

$261,000,000 10X Capital Venture Acquisition Corp. III 26,100,000 Units

Table of Contents FILED PURSUANT TO RULE 424(b)(4) REGISTRATION NO. 333-253868 PROSPECTUS $261,000,000 10X Capital Venture Acquisition Corp. III 26,100,000 Units 10X Capital Venture Acquisition Corp. III is a blank check company incorporated as a Cayman Islands exempted company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or simila

January 14, 2022 EX-10.2

Investment Management Trust Agreement, dated January 11, 2022, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on January 14, 2022).

EXHIBIT 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of January 11, 2022 by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on

January 14, 2022 EX-10.4

Private Placement Units Purchase Agreement, dated January 11, 2022, by and between the Company and the Sponsor (Incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on January 14, 2022).

EXHIBIT 10.4 PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of January 11, 2022 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and 10X Capital SPAC Sponsor III LLC,

January 14, 2022 EX-99.1

10X Capital Venture Acquisition Corp. III Announces Pricing of Upsized $261 Million Initial Public Offering

EX-99.1 11 d291511dex991.htm EX-99.1 Exhibit 99.1 10X Capital Venture Acquisition Corp. III Announces Pricing of Upsized $261 Million Initial Public Offering New York, NY, Jan. 11, 2022 (GLOBE NEWSWIRE) — 10X Capital Venture Acquisition Corp. III (the “Company”) today announced the pricing of its upsized initial public offering of 26,100,000 units at a price of $10.00 per unit. The units will be l

January 14, 2022 EX-1.1

Underwriting Agreement, dated January 11, 2022, by and between the Company and Cantor Fitzgerald & Co., as representative of the underwriters.

EX-1.1 2 d291511dex11.htm EX-1.1 Exhibit 1.1 Execution Version UNDERWRITING AGREEMENT between 10X CAPITAL VENTURE ACQUISITION CORP. III and CANTOR FITZGERALD & CO. Dated: January 11, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III UNDERWRITING AGREEMENT New York, New York January 11, 2022 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Several Underwriters

January 14, 2022 EX-10.1

Letter Agreement, dated January 11, 2022, by and among the Company, its executive officers, its directors and the Sponsor (Incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on January 14, 2022).

EX-10.1 5 d291511dex101.htm EX-10.1 EXHIBIT 10.1 January 11, 2022 10X Capital Venture Acquisition Corp. II 1 World Trade Center, 85th Floor New York, NY 10007 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among 10X Capital Venture Acqu

January 14, 2022 EX-3.1

Amended and Restated Memorandum and Articles of Association.

Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X CAPITAL VENTURE ACQUISITION CORP. III (ADOPTED BY SPECIAL RESOLUTION DATED 11 JANUARY 2022 AND EFFECTIVE ON 11 JANUARY 2022) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASS

January 14, 2022 EX-4.1

Warrant Agreement, dated January 11, 2022, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Incorporated by reference as Exhibit 4.1 to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on January 14, 2022).

EXHIBIT 4.1 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this ?Agreement?), dated as of January 11, 2021, is by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent?, and also referred to herein as the ?Transfer Agent?). WH

January 14, 2022 EX-99.2

10X Capital Venture Acquisition Corp. III Announces Closing of Upsized $300 Million Initial Public Offering

EX-99.2 12 d291511dex992.htm EX-99.2 Exhibit 99.2 10X Capital Venture Acquisition Corp. III Announces Closing of Upsized $300 Million Initial Public Offering New York, NY , Jan. 14, 2022 (GLOBE NEWSWIRE) — 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U) (the “Company”) today announced that it closed its initial public offering of 30,000,000 units, which was upsized, and includes 3,900,000

January 14, 2022 EX-10.3

Registration Rights Agreement, dated January 11, 2022, by and among the Company, the Sponsor, Cantor and the other holders party thereto (Incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on January 14, 2022).

EX-10.3 7 d291511dex103.htm EX-10.3 EXHIBIT 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 11, 2022, is made and entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the “Sponsor”), Cantor Fit

January 14, 2022 EX-10.5

Private Placement Units Purchase Agreement, dated January 11, 2022, by and between the Company and Cantor (Incorporated by reference to the corresponding exhibit the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on January 14, 2022).

EXHIBIT 10.5 PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of January 11, 2022 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Cantor Fitzgerald & Co. (the ?Purc

January 14, 2022 EX-10.6

Administrative Services Agreement, dated January 11, 2022, by and between the Company and the Sponsor (Incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K (File No. 001-41216), filed with the SEC on January 14, 2022).

EX-10.6 10 d291511dex106.htm EX-10.6 Exhibit 10.6 10X CAPITAL VENTURE ACQUISITION CORP. III 1 World Trade Center, 85th Floor New York, NY 10007 January 11, 2022 10X Capital SPAC Sponsor III LLC 1 World Trade Center, 85th Floor New York, NY 10007 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this “Agreement”) by and among 10X Capital Venture Acquisition Corp. II

January 14, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

8-K 1 d291511d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 11, 2022 10X CAPITAL VENTURE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 001-41216 98-1594494 (State o

January 11, 2022 S-1MEF

As filed with the U.S. Securities and Exchange Commission on January 11, 2022.

As filed with the U.S. Securities and Exchange Commission on January 11, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 6770 98-1611637 (State or other jurisdiction of in

January 11, 2022 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 10X Capital Venture Acquisition Corp. III (Ex

8-A12B 1 d276146d8a12b.htm 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 98-1611637 (State of incorporation or organizatio

January 10, 2022 CORRESP

* * * [Signature Page Follows]

January 10, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

January 10, 2022 CORRESP

10X Capital Venture Acquisition Corp. III 1 World Trade Center, 85th Floor New York, NY 10007

CORRESP 1 filename1.htm 10X Capital Venture Acquisition Corp. III 1 World Trade Center, 85th Floor New York, NY 10007 January 10, 2022 VIA EDGAR Ruairi Regan and Jim Lopez U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: 10X Capital Venture Acquisition Corp. III Registration Statement on Form S-1 Filed March 4, 2021, as amended F

January 4, 2022 EX-10.1

Form of Letter Agreement among the Registrant, 10X Capital SPAC Sponsor III LLC and each of the executive officers and directors of the Registrant.

EX-10.1 4 d145071dex101.htm EX-10.1 Exhibit 10.1 [●], 2022 10X Capital Venture Acquisition Corp. II 1 World Trade Center, 85th Floor New York, NY 10007 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among 10X Capital Venture Acquisition

January 4, 2022 S-1/A

As filed with the U.S. Securities and Exchange Commission on January 4, 2022.

Table of Contents As filed with the U.S. Securities and Exchange Commission on January 4, 2022. Registration No. 333-253868 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 6 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A

January 4, 2022 EX-10.9

Form of Administrative Services Agreement between the Registrant and 10X Capital SPAC Sponsor III LLC.

EX-10.9 8 d145071dex109.htm EX-10.9 Exhibit 10.9 10X CAPITAL VENTURE ACQUISITION CORP. III 1 World Trade Center, 85th Floor New York, NY 10007 [●], 2022 10X Capital SPAC Sponsor III LLC 1 World Trade Center, 85th Floor New York, NY 10007 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this “Agreement”) by and among 10X Capital Venture Acquisition Corp. III (the “

January 4, 2022 EX-10.5

Form of Private Placement Units Purchase Agreement between the Registrant and Cantor Fitzgerald & Co.

Exhibit 10.5 PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of [?], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Cantor Fitzgerald & Co. (the ?Purchaser?)

January 4, 2022 EX-1.1

Form of Underwriting Agreement.

EX-1.1 2 d145071dex11.htm EX-1.1 Exhibit 1.1 UNDERWRITING AGREEMENT between 10X CAPITAL VENTURE ACQUISITION CORP. III and CANTOR FITZGERALD & CO. Dated: [ ], 2022 10X CAPITAL VENTURE ACQUISITION CORP. III UNDERWRITING AGREEMENT New York, New York [ ], 2022 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Several Underwriters named on Schedule A hereto Ladie

January 4, 2022 EX-10.2

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.

EX-10.2 5 d145071dex102.htm EX-10.2 Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2022 by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company

January 4, 2022 EX-10.3

Form of Registration Rights Agreement among the Registrant, 10X Capital SPAC Sponsor III LLC and the Holders signatory thereto.

Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2022, is made and entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the ?Sponsor?), Cantor Fitzgerald & Co. (?Cantor?) and the undersigne

January 4, 2022 EX-3.2

Form of Amended and Restated Memorandum and Articles of Association.

Exhibit 3.2 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X CAPITAL VENTURE ACQUISITION CORP. III (ADOPTED BY SPECIAL RESOLUTION DATED [DATE] AND EFFECTIVE ON [DATE]) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF 10X CA

January 3, 2022 CORRESP

* * * [Signature Page Follows]

January 3, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

January 3, 2022 CORRESP

10X Capital Venture Acquisition Corp. III 1 World Trade Center, 85th Floor New York, NY 10007

10X Capital Venture Acquisition Corp. III 1 World Trade Center, 85th Floor New York, NY 10007 January 3, 2021 VIA EDGAR Ruairi Regan and Jim Lopez U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: 10X Capital Venture Acquisition Corp. III Registration Statement on Form S-1 Filed March 4, 2021, as amended File No. 333-253868 Dear M

December 30, 2021 CORRESP

10X Capital Venture Acquisition Corp. III 1 World Trade Center, 85th Floor New York, NY 10007

10X Capital Venture Acquisition Corp. III 1 World Trade Center, 85th Floor New York, NY 10007 December 30, 2021 VIA EDGAR Ruairi Regan and Jim Lopez U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: 10X Capital Venture Acquisition Corp. III Registration Statement on Form S-1 Filed March 4, 2021, as amended File No. 333-253868 Dear

December 30, 2021 CORRESP

* * * [Signature Page Follows]

CORRESP 1 filename1.htm December 30, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ruairi Regan and Jim Lopez Re: 10X Capital Venture Acquisition Corp. III Registration Statement on Form S-1 Filed March 4, 2021 File No. 333-253868 Dear Mr. Regan and Mr. Lopez: Pursuant to Rule 461 under the Secur

December 16, 2021 EX-10.3

Form of Registration Rights Agreement among the Registrant, 10X Capital SPAC Sponsor III LLC and the Holders signatory thereto.

Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2021, is made and entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the ?Sponsor?), Cantor Fitzgerald & Co. (?Cantor?) and the undersigne

December 16, 2021 EX-4.4

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.

EX-4.4 5 d145071dex44.htm EX-4.4 Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of [•], 2021, is by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”, and also referred to herein as

December 16, 2021 EX-3.2

Form of Amended and Restated Memorandum and Articles of Association.

EX-3.2 3 d145071dex32.htm EX-3.2 Exhibit 3.2 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X CAPITAL VENTURE ACQUISITION CORP. III (ADOPTED BY SPECIAL RESOLUTION DATED [DATE] AND EFFECTIVE ON [DATE]) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED ME

December 16, 2021 EX-1.1

Form of Underwriting Agreement.

EX-1.1 2 d145071dex11.htm EX-1.1 Exhibit 1.1 UNDERWRITING AGREEMENT between 10X CAPITAL VENTURE ACQUISITION CORP. III and CANTOR FITZGERALD & CO. Dated: [ ], 2021 10X CAPITAL VENTURE ACQUISITION CORP. III UNDERWRITING AGREEMENT New York, New York [ ], 2021 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Several Underwriters named on Schedule A hereto Ladie

December 16, 2021 EX-10.5

Form of Private Placement Units Purchase Agreement between the Registrant and Cantor Fitzgerald & Co.

Exhibit 10.5 PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of [?], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this ?Agreement?), is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Cantor Fitzgerald & Co. (the ?Purchaser?)

December 16, 2021 EX-10.4

Form of Private Placement Units Purchase Agreement between the Registrant and 10X Capital SPAC Sponsor III LLC.

EX-10.4 11 d145071dex104.htm EX-10.4 Exhibit 10.4 PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of [●], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and 10X

December 16, 2021 EX-10.1

Form of Letter Agreement among the Registrant, 10X Capital SPAC Sponsor III LLC and each of the executive officers and directors of the Registrant.

EX-10.1 8 d145071dex101.htm EX-10.1 Exhibit 10.1 [●], 2021 10X Capital Venture Acquisition Corp. II 1 World Trade Center, 85th Floor New York, NY 10007 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among 10X Capital Venture Acquisition

December 16, 2021 S-1/A

As filed with the U.S. Securities and Exchange Commission on December 16, 2021.

Table of Contents As filed with the U.S. Securities and Exchange Commission on December 16, 2021. Registration No. 333-253868 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 6770 N

December 16, 2021 EX-10.2

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.

Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of [?], 2021 by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-

December 16, 2021 EX-4.1

Specimen Unit Certificate.

EX-4.1 4 d145071dex41.htm EX-4.1 Exhibit 4.1 NUMBER UNITS U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [ ] 10X CAPITAL VENTURE ACQUISITION CORP. III UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-FOURTH OF ONE REDEEMABLE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one Class

December 6, 2021 S-1/A

As filed with the U.S. Securities and Exchange Commission on December 3, 2021.

S-1/A 1 d145071ds1a.htm S-1/A Table of Contents As filed with the U.S. Securities and Exchange Commission on December 3, 2021. Registration No. 333-253868 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its c

July 2, 2021 CORRESP

Analysis of Warrants

CORRESP 1 filename1.htm July 2, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D.C. 20549 Attn: James Lopez White & Case LLP 1221 Avenue of the Americas New York, NY 10020-1095 T +1 212 819 8200 whitecase.com Re: 10X Capital Venture Acquisition Corp. III Amended Registration Statement

July 2, 2021 S-1/A

As filed with the U.S. Securities and Exchange Commission on July 2, 2021.

S-1/A 1 d145071ds1a.htm S-1/A As filed with the U.S. Securities and Exchange Commission on July 2, 2021. Registration No. 333-253868 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands

July 2, 2021 EX-4.4

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.

Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this ?Agreement?), dated as of [?], 2021, is by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent?, and also referred to herein as the ?Transfer Agent?). WHEREAS,

June 15, 2021 EX-1.1

Form of Underwriting Agreement.

Exhibit 1.1 UNDERWRITING AGREEMENT between 10X CAPITAL VENTURE ACQUISITION CORP. III and CANTOR FITZGERALD & CO. Dated: [ ], 2021 10X CAPITAL VENTURE ACQUISITION CORP. III UNDERWRITING AGREEMENT New York, New York [ ], 2021 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Several Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned,

June 15, 2021 EX-4.4

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.

Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this ?Agreement?), dated as of [?], 2021, is by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent?, and also referred to herein as the ?Transfer Agent?). WHEREAS,

June 15, 2021 EX-4.3

Specimen Warrant Certificate.*

Exhibit 4.3 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW 10X CAPITAL VENTURE ACQUISITION CORP. III Incorporated Under the Laws of the Cayman Islands CUSIP [] Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the

June 15, 2021 S-1/A

As filed with the U.S. Securities and Exchange Commission on June 15, 2021.

Table of Contents As filed with the U.S. Securities and Exchange Commission on June 15, 2021. Registration No. 333-253868 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (

June 2, 2021 S-1/A

As filed with the U.S. Securities and Exchange Commission on June 2, 2021.

As filed with the U.S. Securities and Exchange Commission on June 2, 2021. Registration No. 333-253868 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or other juri

June 2, 2021 EX-10.1

Form of Letter Agreement among the Registrant, 10X Capital SPAC Sponsor III LLC and each of the executive officers and directors of the Registrant.*

Exhibit 10.1 [?], 2021 10X Capital Venture Acquisition Corp. II 1 World Trade Center, 85th Floor New York, NY 10007 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempte

June 2, 2021 EX-99.1

Form of Audit Committee Charter.*

Exhibit 99.1 10X CAPITAL VENTURE ACQUISITION CORP. III AUDIT COMMITTEE CHARTER Effective [ ], 2021 I. PURPOSES The Audit Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of 10X Capital Venture Acquisition Corp. III (the “Company”) to assist the Board in its oversight of the accounting and financial reporting processes of the Company and the Company’s compliance with

June 2, 2021 EX-3.2

Form of Amended and Restated Memorandum and Articles of Association.*

EX-3.2 2 d145071dex32.htm EX-3.2 Exhibit 3.2 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X CAPITAL VENTURE ACQUISITION CORP. III (ADOPTED BY SPECIAL RESOLUTION DATED [DATE] AND EFFECTIVE ON [DATE]) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED ME

June 2, 2021 EX-4.1

Specimen Unit Certificate.*

Exhibit 4.1 NUMBER UNITS U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [ ] 10X CAPITAL VENTURE ACQUISITION CORP. III UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-FOURTH OF ONE REDEEMABLE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner of Units. Each Unit (?Unit?) consists of one Class A ordinary share, par value $0.0

June 2, 2021 EX-10.9

Form of Administrative Services Agreement between the Registrant and 10X Capital SPAC Sponsor III LLC.*

Exhibit 10.9 10X CAPITAL VENTURE ACQUISITION CORP. III 1 World Trade Center, 85th Floor New York, NY 10007 [?], 2021 10X Capital SPAC Sponsor III LLC 1 World Trade Center, 85th Floor New York, NY 10007 Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this ?Agreement?) by and among 10X Capital Venture Acquisition Corp. III (the ?Company?) and 10X Capital SPAC Spons

June 2, 2021 EX-10.6

Form of Indemnity Agreement.*

EX-10.6 10 d145071dex106.htm EX-10.6 Exhibit 10.6 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [•], 2021, by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or

June 2, 2021 EX-99.6

Form of Nominating and Corporate Governance Committee Charter. *

EX-99.6 15 d145071dex996.htm EX-99.6 Exhibit 99.6 10X CAPITAL VENTURE ACQUISITION CORP. III NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER Effective , 2021 I. INTRODUCTION The Nominating and Corporate Governance Committee (the “Committee”) is appointed by the Board of Directors (the “Board”) of 10X Capital Venture Acquisition Corp. III (the “Company”) to: (i) identify and screen individuals

June 2, 2021 EX-4.2

Specimen Class A Ordinary Share Certificate.*

Exhibit 4.2 NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [ ] 10X CAPITAL VENTURE ACQUISITION CORP. III CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner of fully paid and non-assessable Class A ordinary shares, par value $0.0001 per share (the ?Ordinary Shares?), of 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), transferable on the

June 2, 2021 EX-10.5

Form of Private Placement Units Purchase Agreement between the Registrant and Cantor Fitzgerald & Co.*

EX-10.5 9 d145071dex105.htm EX-10.5 Exhibit 10.5 PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of [•], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and Canto

June 2, 2021 EX-10.3

Form of Registration Rights Agreement among the Registrant, 10X Capital SPAC Sponsor III LLC and the Holders signatory thereto.*

Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2021, is made and entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?), 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the ?Sponsor?), Cantor Fitzgerald & Co. (?Cantor?) and the undersigne

June 2, 2021 EX-10.4

Form of Private Placement Units Purchase Agreement between the Registrant and 10X Capital SPAC Sponsor III LLC.*

Exhibit 10.4 PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of [•], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and 10X Capital SPAC Sponsor III LLC, a Cayma

June 2, 2021 EX-14

Form of Code of Business Conduct and Ethics.*

Exhibit 14 10X CAPITAL VENTURE ACQUISITION CORP. III CODE OF BUSINESS CONDUCT AND ETHICS Effective , 2021 I. INTRODUCTION The Board of Directors (the “Board”) of 10X Capital Venture Acquisition Corp. III has adopted this code of business conduct and ethics (this “Code”), as amended from time to time by the Board and which is applicable to all of the Company’s directors, officers and employees (to

June 2, 2021 EX-99.2

Form of Compensation Committee Charter.*

Exhibit 99.2 10X CAPITAL VENTURE ACQUISITION CORP. III COMPENSATION COMMITTEE CHARTER Effective [ ], 2021 I. PURPOSES The Compensation Committee (the ?Committee?) is appointed by the Board of Directors (the ?Board?) of 10X Capital Venture Acquisition Corp. III (the ?Company?) to: (A) assist the Board in overseeing the Company?s employee compensation policies and practices, including (i) determinin

June 2, 2021 EX-10.2

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.*

EX-10.2 6 d145071dex102.htm EX-10.2 Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [•], 2021 by and between 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company

March 4, 2021 EX-99.4

Consent of Boris Silver.

Exhibit 99.4 Consent to be Named as a Director Nominee In connection with the filing by 10X Capital Venture Acquisition Corp. III of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors

March 4, 2021 EX-99.3

Consent of Christopher Jurasek.

EX-99.3 6 d145071dex993.htm EX-99.3 Exhibit 99.3 Consent to be Named as a Director Nominee In connection with the filing by 10X Capital Venture Acquisition Corp. III of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as

March 4, 2021 S-1

Power of Attorney (included on signature page to the initial filing of this Registration Statement).*

Table of Contents As filed with the U.S. Securities and Exchange Commission on March 4, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 10X Capital Venture Acquisition Corp. III (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or other jurisdicti

March 4, 2021 EX-10.7

Promissory Note issued to 10X Capital SPAC Sponsor III LLC.*

Exhibit 10.7 THIS PROMISSORY NOTE (?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY

March 4, 2021 EX-3.1

Memorandum and Articles of Association.*

EX-3.1 2 d145071dex31.htm EX-3.1 Exhibit 3.1 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES MEMORANDUM AND ARTICLES OF ASSOCIATION OF 10X CAPITAL VENTURE ACQUISITION CORP. III Auth Code:E14563871279 www.verify.gov.ky THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES MEMORANDUM OF ASSOCIATION OF 10X CAPITAL VENTURE ACQUISITION CORP. III 1

March 4, 2021 EX-10.8

Securities Subscription Agreement between the Registrant and 10X Capital SPAC Sponsor III LLC.

Exhibit 10.8 10X Capital Venture Acquisition Corp. III 1 World Trade Center, 85th Floor New York, NY 10007 February 18, 2021 10X Capital SPAC Sponsor III LLC 1 World Trade Center, 85th Floor New York, NY 10007 RE: Securities Subscription Agreement Ladies and Gentlemen: 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (the ?Company?, ?we? or ?us?), is pleased to accept t

March 4, 2021 EX-99.5

Consent of Woodrow H. Levin.

EX-99.5 8 d145071dex995.htm EX-99.5 Exhibit 99.5 Consent to be Named as a Director Nominee In connection with the filing by 10X Capital Venture Acquisition Corp. III of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista